Close

Canaccord Genuity Maintains a 'Buy' on NuVasive (NUVA); Q2 Review

July 26, 2012 1:53 PM EDT
Get Alerts NUVA Hot Sheet
Price: $39.75 --0%

Rating Summary:
    11 Buy, 21 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 10 | Down: 11 | New: 6
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on NuVasive (NASDAQ: NUVA) price target of $27.00.

Analyst, William J. Plovanic, said, "We maintain our rating on NuVasive following Q2/12 results. We note that while non-GAAP earnings outperformed relative to our and consensus expectations, revenue results were somewhat disappointing, (despite being in line). Specifically, given the strong Q1/12 and our expectations for a continued rebound in the US metal business, Q2/12 results were driven by OUS and US biologics, and not metal. That said, management increased 2012 guidance on the
top and bottom lines and multiple new products are expected to drive H2/12 and 2013 growth."

For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.

Shares of NuVasive closed at $22.92 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View

Related Entities

Earnings, Canaccord Genuity